Millennium Management
HELP

Millennium Management’s Helus Pharma Inc. Common Stock HELP Stock Holding History

Millennium Management’s Portfolio HELP Stock Details HELP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$331K Buy
+50,000
New +$250K ﹤0.01% 5060

Other funds holding HELP

VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $767M AUM 119.71% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
DA
DCF Advisers Greenwich, Connecticut $566M AUM 197.74% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Millennium Management's HELP Position: Q2 2026 in Review

Millennium Management increased its Helus Pharma Inc. Common Stock (HELP) stake by 9% in Q2 2026, buying an estimated $1.08M and bringing the position to 2,632,156 shares worth $17.4M. The position accounts for 0.01% of the portfolio, ranked #1752.

Millennium Management first reported a position in HELP in Q3 2022 and has held it in 6 quarters since. 99 funds tracked by Wall St. Rank hold HELP as of Q2 2026.

  • Millennium Management held 2,632,156 shares of Helus Pharma Inc. Common Stock worth $17.4M as of Q2 2026.
  • Millennium Management bought 216,315 Helus Pharma Inc. Common Stock shares in Q2 2026, an estimated $1.08M.
  • Helus Pharma Inc. Common Stock made up 0.01% of Millennium Management's portfolio in Q2 2026, its #1752 holding.
  • Millennium Management first reported a position in Helus Pharma Inc. Common Stock in Q3 2022 and has held it in 6 quarters since.
  • 99 funds tracked by Wall St. Rank held Helus Pharma Inc. Common Stock as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.